
After 35 years spent making complex biology behave at scale, ElevateBio's chief executive is betting that genetic medicine's next breakthrough will look less like a eureka moment and more like a reliable process.
Catalonia can produce the science. Getting it into everyday care is another job. Biocat is building the connections, training and routes into the health system that make that journey possible.
Current Health began with a wearable, grew into a hospital-at-home operating system, and became a $400 million retail-health wager. Its second act is more disciplined: help hospitals and drugmakers move the hardest care out of the building without making clinicians gamble on safety.